Resultados da pesquisa - (( e nat computer case now ) OR ((( j party companies a new ) OR ( j nart compared law non ))))*

Pesquisas alternativas:
nat » natl (Expandir a Pesquisa)
nart » nar (Expandir a Pesquisa), nara (Expandir a Pesquisa), naro (Expandir a Pesquisa)

21

Automating Construction of Machine Learning Models With Clinical Big Data: Proposal Rationale and Methods

Automating Construction of Machine Learning Models With Clinical Big Data: Proposal Rationale and Methods

Por Luo, Gang, Stone, Bryan L, Johnson, Michael D, Tarczy-Hornoch, Peter, Wilcox, Adam B, Mooney, Sean D, Sheng, Xiaoming, Haug, Peter J, Nkoy, Flory L
Publicado no JMIR Res Protoc (2017)

“... effectively. Facing a shortage in the United States of data scientists and hiring competition from companies...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

22

Behaviour change for better health: nutrition, hygiene and sustainability

Behaviour change for better health: nutrition, hygiene and sustainability

Por Newson, Rachel S, Lion, Rene, Crawford, Robert J, Curtis, Valerie, Elmadfa, Ibrahim, Feunekes, Gerda IJ, Hicks, Cheryl, van Liere, Marti, Lowe, C Fergus, Meijer, Gert W, Pradeep, BV, Reddy, K Srinath, Sidibe, Myriam, Uauy, Ricardo
Publicado em 2013

“..., of interventions. The symposium highlighted a number of key scientific challenges for Unilever and other parties...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

23

Economic impact of new active substance status on EU payers’ budgets: example of dimethyl fumarate (Tecfidera(®)) for multiple sclerosis

Economic impact of new active substance status on EU payers’ budgets: example of dimethyl fumarate (Tecfidera(®)) for multiple sclerosis

Por Toumi, Mondher, Jadot, Guy
Publicado no J Mark Access Health Policy (2014)

“... Products for Human Use (CHMP) denied Tecfidera(®) NASs and, following a company appeal, reversed its...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

24

New drug regulations in France: what are the impacts on market access? Part 2 – impacts on market access and impacts for the pharmaceutical industry

New drug regulations in France: what are the impacts on market access? Part 2 – impacts on market access and impacts for the pharmaceutical industry

Por Rémuzat, Cécile, Toumi, Mondher, Falissard, Bruno
Publicado no J Mark Access Health Policy (2013)

“... as by two laws that came into force in December 2011. This new environment has been described and analyzed...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

25

REFUTANDO A DEMOCRACIA

REFUTANDO A DEMOCRACIA

Por Black, Bob
Publicado em 2019

Obter o texto integral

Online

26

Implementation of proteomic biomarkers: making it work

Implementation of proteomic biomarkers: making it work

Por Mischak, Harald, Ioannidis, John PA, Argiles, Angel, Attwood, Teresa K, Bongcam-Rudloff, Erik, Broenstrup, Mark, Charonis, Aristidis, Chrousos, George P, Delles, Christian, Dominiczak, Anna, Dylag, Tomasz, Ehrich, Jochen, Egido, Jesus, Findeisen, Peter, Jankowski, Joachim, Johnson, Robert W, Julien, Bruce A, Lankisch, Tim, Leung, Hing Y, Maahs, David, Magni, Fulvio, Manns, Michael P, Manolis, Efthymios, Mayer, Gert, Navis, Gerjan, Novak, Jan, Ortiz, Alberto, Persson, Frederik, Peter, Karlheinz, Riese, Hans H, Rossing, Peter, Sattar, Naveed, Spasovski, Goce, Thongboonkerd, Visith, Vanholder, Raymond, Schanstra, Joost P, Vlahou, Antonia
Publicado em 2012

“... to appropriate specimens and insufficient funding, the need to validate new biomarker utility in interventional...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

27

Breast Biopsy: A Study of Cost-effectiveness

Breast Biopsy: A Study of Cost-effectiveness

Por Doberneck, Raymond C.
Publicado em 1980

“... of breast biopsies at the University of New Mexico and to compare such data with 1) cost-effectiveness...”
Obter o texto integral
Obter o texto integral

Artigo

28

Moral dilemmas of community pharmacists: a narrative study

Moral dilemmas of community pharmacists: a narrative study

Por Kruijtbosch, Martine, Göttgens-Jansen, Wilma, Floor-Schreudering, Annemieke, van Leeuwen, Evert, Bouvy, Marcel L.
Publicado no Int J Clin Pharm (2017)

“...Background Pharmacists are increasingly involved in patient care. This new role in a complex...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

29

Personalized medicine – a tailored health care system: challenges and opportunities

Personalized medicine – a tailored health care system: challenges and opportunities

Por Louca, Soulla
Publicado em 2012

“... thinking to propose new ways for the diagnosis and therapy of diseases, integrated with a planned trans...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

30

RESTORATIVE ENVIRONMENTAL JUSTICE: A WAY TO IMPLEMENT THE ECOLOGICAL DUTIES

RESTORATIVE ENVIRONMENTAL JUSTICE: A WAY TO IMPLEMENT THE ECOLOGICAL DUTIES

Por Parola, Giulia
Publicado em 2019

“... of human responsibilities towards all forms of life, including non-human life1,and a special duty to “care...”
Obter o texto integral

Online

31

Paying for On-Patent Pharmaceuticals: Limit Prices and the Emerging Role of a Pay for Outcomes Approach

Paying for On-Patent Pharmaceuticals: Limit Prices and the Emerging Role of a Pay for Outcomes Approach

Por Fuller, Richard L., Goldfield, Norbert
Publicado no J Ambul Care Manage (2016)

“... to adopt use of a new pharmaceutical, they would require objective third-party evaluation...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

32

A doutrina chinesa da Ascensão Pacífica: histórico e mudanças recentes

A doutrina chinesa da Ascensão Pacífica: histórico e mudanças recentes

Por Valente, Leonardo, Ciconha, Thiago, Ciconha, Thiago
Publicado em 2022

“... Ascensão Pacífica e mostrar que adaptações que foram feitas por conta do maior protagonismo da China...”
Obter o texto integral

Online

33

“ANARCHISTIC SPAIN” – IS AN ANARCHISTIC SYSTEM CHANGE POSSIBLE AFTER THE CORONA CRISIS? A COMPARATIVE ANALYSIS OF SPAIN´S DEVELOPMENT

“ANARCHISTIC SPAIN” – IS AN ANARCHISTIC SYSTEM CHANGE POSSIBLE AFTER THE CORONA CRISIS? A COMPARATIVE ANALYSIS OF SPAIN´S DEVELOPMENT

Por Emery Trindade, Victor Mignone, Costantini, Andrea, Koller, Eva
Publicado em 2020

“.... Investigamos se esse é realmente o caso da atual crise. Para fazer isso, a teoria da acumulação e participação...”
Obter o texto integral

Online

34

Literature Review of Mergers and Acquisitions with the Aim to Obtain Technology and Knowledge

Literature Review of Mergers and Acquisitions with the Aim to Obtain Technology and Knowledge

Por Elena Ochirova
Publicado em 2019-12-01

“... between companies - have contradictory results on both parties of a deal. Based on the existed literature...”

Artigo

35

Advances in digital forensics II

Advances in digital forensics II

Por IFIP International Conference on Digital Forensics, Olivier, Martin S., Shenoi, Sujeet.
Publicado em 2006

“... of digital forensics beyond traditional computer crime investigations. Practically every crime now involves...”
Obter o texto integral

Livro

36

Pharmaceutical market access in emerging markets: concepts, components, and future

Pharmaceutical market access in emerging markets: concepts, components, and future

Por Kumar, Anuj, Juluru, Karthaveerya, Thimmaraju, Phani Kishore, Reddy, Jayachandra, Patil, Anand
Publicado no J Mark Access Health Policy (2014)

“... is the need of the hour. A market access framework with specific tools and tactics will help companies to plan...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

37

Personal genomics services: whose genomes?

Personal genomics services: whose genomes?

Por Gurwitz, David, Bregman-Eschet, Yael
Publicado em 2009

“...New companies offering personal whole-genome information services over the internet are dynamic...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

38

Continuous improvement of fitness-for-duty management programs for workers engaging in stabilizing and decommissioning work at the Fukushima Daiichi Nuclear Power Plant

Continuous improvement of fitness-for-duty management programs for workers engaging in stabilizing and decommissioning work at the Fukushima Daiichi Nuclear Power Plant

Por Mori, Koji, Tateishi, Seiichiro, Kubo, Tatsuhiko, Kobayashi, Yuichi, Hiraoka, Ko, Kawashita, Futoshi, Hayashi, Takeshi, Kiyomoto, Yoshifumi, Kobashi, Masaki, Fukai, Kota, Tahara, Hiroyuki, Okazaki, Ryuji, Ogami, Akira, Igari, Kazuyuki, Suzuki, Katsunori, Kikuchi, Hiroshi, Sakai, Kazuhiro
Publicado no J Occup Health (2017)

Assuntos: “...Case Study...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

39

Using multicriteria decision analysis during drug development to predict reimbursement decisions

Using multicriteria decision analysis during drug development to predict reimbursement decisions

Por Williams, Paul, Mauskopf, Josephine, Lebiecki, Jake, Kilburg, Anne
Publicado no J Mark Access Health Policy (2014)

“... was to present a process for using multicriteria decision analysis (MCDA) by a pharmaceutical company to estimate...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

40

Commercial product exploitation from marine microbial biodiversity: some legal and IP issues

Commercial product exploitation from marine microbial biodiversity: some legal and IP issues

Por Tichet, Camille, Nguyen, Hong Khanh, Yaakoubi, Sefia El, Bloch, Jean‐François
Publicado em 2010

“...The biodiversity found in the marine environment is remarkable and yet largely unknown compared...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo